Gastroenterology
3 drugs are in development for Primary Biliary Cholangitis.
- Companies
- 2
- Clinical trials
- 9
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Primary Biliary Cholangitis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(3)
| Drug | Company |
|---|---|
| oca | INTERCEPT PHARMACEUTICALS, INC. (ICPT) |
| oca + bezafibrate | INTERCEPT PHARMACEUTICALS, INC. (ICPT) |
| volixibat | Mirum Pharmaceuticals, Inc. (MIRM) |
About this indication
Primary Biliary Cholangitis context
Gastroenterology·MeSH: Liver Cirrhosis, Biliary (D008105)
Frequently asked questions
How many drugs are in development for Primary Biliary Cholangitis?
BioSniper tracks 3 drugs in development for Primary Biliary Cholangitis across 2 companies.
How many clinical trials target Primary Biliary Cholangitis?
There are 9 clinical trials targeting Primary Biliary Cholangitis tracked by BioSniper.